My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium.

    Ruvinov E, Sharabani-Yosef O, Nagler A, Einbinder T, Feinberg MS, Holbova R, Douvdevani A, Leor J.

    Fibrogenesis Tissue Repair. 2008 Nov 3;1(1):7.PMID: 19014419 [PubMed]Free PMC ArticleFree textRelated citations

    2.

    Therapeutic effectiveness of a single vs multiple doses of erythropoietin after experimental myocardial infarction in rats.

    Moon C, Krawczyk M, Lakatta EG, Talan MI.

    Cardiovasc Drugs Ther. 2006 Aug;20(4):245-51.PMID: 17019537 [PubMed - indexed for MEDLINE]Related citations

    3.

    [Transplantation of fetal cardiomyocyte regenerates infarcted myocardium in rats]

    Gao LR, Wang ZG, Zhang NK, He S, Yao L, Ning HY, Kang XL, Fei YX, Zhu ZM, Yang Y.

    Zhonghua Yi Xue Za Zhi. 2003 Oct 25;83(20):1818-22. Chinese. PMID: 14642091 [PubMed - indexed for MEDLINE]Related citations

    4.

    Human embryonic stem cell transplantation to repair the infarcted myocardium.

    Leor J, Gerecht S, Cohen S, Miller L, Holbova R, Ziskind A, Shachar M, Feinberg MS, Guetta E, Itskovitz-Eldor J.

    Heart. 2007 Oct;93(10):1278-84. Epub 2007 Jun 12.PMID: 17566061 [PubMed - indexed for MEDLINE]Related citations

    5.

    Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production.

    Mihov D, Bogdanov N, Grenacher B, Gassmann M, Zünd G, Bogdanova A, Tavakoli R.

    Eur J Cardiothorac Surg. 2009 May;35(5):839-46; discussion 846. Epub 2009 Feb 23.PMID: 19237290 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    6.

    The inhibition of postinfarct ventricle remodeling without polycythaemia following local sustained intramyocardial delivery of erythropoietin within a supramolecular hydrogel.

    Wang T, Jiang XJ, Lin T, Ren S, Li XY, Zhang XZ, Tang QZ.

    Biomaterials. 2009 Sep;30(25):4161-7. Epub 2009 Jun 18.PMID: 19539990 [PubMed - indexed for MEDLINE]Related citations

    7.

    A statistical pattern recognition approach for determining cellular viability and lineage phenotype in cultured cells and murine bone marrow.

    Quinn J, Fisher PW, Capocasale RJ, Achuthanandam R, Kam M, Bugelski PJ, Hrebien L.

    Cytometry A. 2007 Aug;71(8):612-24.PMID: 17542025 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    8.

    Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats.

    Moon C, Krawczyk M, Ahn D, Ahmet I, Paik D, Lakatta EG, Talan MI.

    Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11612-7. Epub 2003 Sep 19.PMID: 14500913 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    9.

    Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties.

    Moon C, Krawczyk M, Paik D, Coleman T, Brines M, Juhaszova M, Sollott SJ, Lakatta EG, Talan MI.

    J Pharmacol Exp Ther. 2006 Mar;316(3):999-1005. Epub 2005 Nov 23.PMID: 16306273 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    10.

    Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window.

    Moon C, Krawczyk M, Paik D, Lakatta EG, Talan MI.

    Cardiovasc Drugs Ther. 2005 Aug;19(4):243-50.PMID: 16187008 [PubMed - indexed for MEDLINE]Related citations

    11.

    Cellular cardiomyoplasty of cardiac fibroblasts by adenoviral delivery of MyoD ex vivo: an unlimited source of cells for myocardial repair.

    Etzion S, Barbash IM, Feinberg MS, Zarin P, Miller L, Guetta E, Holbova R, Kloner RA, Kedes LH, Leor J.

    Circulation. 2002 Sep 24;106(12 Suppl 1):I125-30.PMID: 12354721 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    12.

    Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.

    Leor J, Tuvia S, Guetta V, Manczur F, Castel D, Willenz U, Petneházy O, Landa N, Feinberg MS, Konen E, Goitein O, Tsur-Gang O, Shaul M, Klapper L, Cohen S.

    J Am Coll Cardiol. 2009 Sep 8;54(11):1014-23.PMID: 19729119 [PubMed - indexed for MEDLINE]Related citations

    13.

    Chemokine stromal cell-derived factor 1/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction.

    Zhuang Y, Chen X, Xu M, Zhang LY, Xiang F.

    Chin Med J (Engl). 2009 Jan 20;122(2):183-7.PMID: 19187644 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    14.

    Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium?

    Chanséaume S, Azarnoush K, Maurel A, Bellamy V, Peyrard S, Bruneval P, Hagège AA, Menasché P.

    Interact Cardiovasc Thorac Surg. 2007 Jun;6(3):293-7. Epub 2007 Mar 26.PMID: 17669846 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    15.

    Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats.

    Wang S, Fei K, Xu YW, Wang LX, Chen YQ.

    Chin Med J (Engl). 2009 Jan 5;122(1):61-7.PMID: 19187619 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    16.

    Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model.

    Klopsch C, Furlani D, Gäbel R, Li W, Pittermann E, Ugurlucan M, Kundt G, Zingler C, Titze U, Wang W, Ong LL, Wagner K, Li RK, Ma N, Steinhoff G.

    J Cell Mol Med. 2009 Apr;13(4):664-79.PMID: 19449462 [PubMed - indexed for MEDLINE]Related citations

    17.

    Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation.

    Camici GG, Stallmach T, Hermann M, Hassink R, Doevendans P, Grenacher B, Hirschy A, Vogel J, Lüscher TF, Ruschitzka F, Gassmann M.

    Methods Enzymol. 2007;435:147-55.PMID: 17998053 [PubMed - indexed for MEDLINE]Related citations

    18.

    Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.

    Wang YQ, Wang M, Zhang P, Song JJ, Li YP, Hou SH, Huang CX.

    Chin Med J (Engl). 2008 Nov 20;121(22):2290-8.PMID: 19080335 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    19.

    Blockades of angiotensin and aldosterone reduce osteopontin expression and interstitial fibrosis infiltration in rats with myocardial infarction.

    Zhang YL, Zhou SX, Lei J, Yuan GY, Wang JF.

    Chin Med J (Engl). 2008 Nov 5;121(21):2192-6.PMID: 19080183 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    20.

    Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium.

    Okada M, Payne TR, Zheng B, Oshima H, Momoi N, Tobita K, Keller BB, Phillippi JA, Péault B, Huard J.

    J Am Coll Cardiol. 2008 Dec 2;52(23):1869-80.PMID: 19038685 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk